Skip to content

Clinical trials

Irritable Bowel Syndrome trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Irritable Bowel Syndrome Country / region: China Clear all

56 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20082
20092
20111
20124
20131
20141
20157
20162
20172
20185
20204
20211
20223
20237
20246
20254
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status24
Completed16
Recruiting12
Not yet recruiting3
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Shandong University7
The First Affiliated Hospital of Soochow University4
Second Affiliated Hospital of Xi'an Jiaotong University3
AstraZeneca2
Beijing Tiantan Hospital2
Chinese University of Hong Kong2
Eli Lilly and Company2
Second Affiliated Hospital, Zhejiang University, School of Medicine2
Shanghai Zhongshan Hospital2
Sir Run Run Shaw Hospital2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Irritable Bowel Syndrome56
Diarrhea7
Abdominal Pain3
Colitis, Ulcerative3
Constipation3
Inflammatory Bowel Diseases3
Anxiety Disorders1
Autism Spectrum Disorder1
Colorectal Neoplasms1
Crohn Disease1

Trials

Showing 26 to 50 of 56. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.